Pub Date : 2024-08-01DOI: 10.1016/j.jogc.2024.102589
Giulia M. Muraca PhD, MPH , Sarka Lisonkova MD, PhD , K.S. Joseph MD, PhD
{"title":"Dispelling Confusion About the Effect of Episiotomy With Operative Vaginal Delivery: A Reply to “Large Databases Cannot Illuminate Practice Variation in the Use of Episiotomy”","authors":"Giulia M. Muraca PhD, MPH , Sarka Lisonkova MD, PhD , K.S. Joseph MD, PhD","doi":"10.1016/j.jogc.2024.102589","DOIUrl":"10.1016/j.jogc.2024.102589","url":null,"abstract":"","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142048086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01DOI: 10.1016/j.jogc.2024.102619
Sebastian R. Hobson M.D., Ph. D., Elissa R. Cohen M.D., M.A., Shital Gandhi M.D., M. Sc. (santé publique), Venu Jain M.D., Ph. D., Kirsten M. Niles M.D., Ph. D., Marie-Ève Roy-Lacroix M.D., Bi Lan Wo M.D.
<div><h3>Objectif</h3><p>Résumer les données probantes actuelles et formuler des recommandations pour le diagnostic et la prise en charge de la cholestase intrahépatique de la grossesse.</p></div><div><h3>Population cible</h3><p>Personnes enceintes atteintes de cholestase intrahépatique de la grossesse.</p></div><div><h3>Options</h3><p>Diagnostiquer la cholestase par le dosage des acides biliaires à jeun ou non, classer la gravité de l’atteinte, déterminer le traitement à offrir, établir la méthode de surveillance du bien-être fœtal, déterminer quand procéder à un accouchement planifié.</p></div><div><h3>Bénéfices, risques et coûts</h3><p>Les personnes atteintes de cholestase intrahépatique de la grossesse présentent un risque accru d’issues périnatales défavorables (naissance prématurée, détresse respiratoire néonatale et hospitalisation en unité de soins intensifs néonatale), et de mortinaissance lorsque le taux d’acides biliaires est de 100 μmol/L ou plus. Il existe une inégalité dans la disponibilité des bilans d’acides biliaires et l’accès rapide aux résultats. Une incertitude règne quant à la manière de traiter et surveiller ces grossesses et de procéder à l’accouchement. L’optimisation des protocoles de diagnostic et de prise en charge peut améliorer les issues maternelles, fœtales et postnatales.</p></div><div><h3>Données probantes</h3><p>Des recherches ont été effectuées dans les bases de données Medline, PubMed, Embase et Cochrane Library, de leur création jusqu’à mars 2023, à partir de termes MeSH et de mots clés liés à la grossesse, à la cholestase intrahépatique de la grossesse, aux acides biliaires, au prurit, à l’acide ursodésoxycholique et à la mortinaissance. Le présent document est un résumé des données probantes et non pas une revue méthodologique.</p></div><div><h3>Méthodes de validation</h3><p>Les auteurs ont évalué la qualité des données probantes et la force des recommandations en utilisant le cadre méthodologique GRADE (Grading of Recommendations, Assessment, Development, and Evaluation). Voir l’<span><span>annexe A</span></span> (<span><span>tableau A1</span></span> pour les définitions et <span><span>tableau A2</span></span> pour l’interprétation des recommandations fortes et faibles).</p></div><div><h3>Professionnels concernés</h3><p>Professionnels de soins obstétricaux, y compris obstétriciens, médecins de famille, infirmières, sages-femmes, spécialistes en médecine fœto-maternelle et radiologistes.</p></div><div><h3>Résumé des médias sociaux</h3><p>La cholestase intrahépatique de la grossesse nécessite un bon diagnostic par dosage des acides biliaires non à jeun pour déterminer la prise en charge optimale et le moment de l’accouchement.</p></div><div><h3>DÉCLARATIONS SOMMAIRES</h3><p></p><ul><li><span>1.</span><span><p>La cholestase intrahépatique de la grossesse est un trouble gravidique fréquent qui se manifeste à la fin du deuxième trimestre ou au troisième trimestre (<em>moyenne</em>).</p></span></li><li><span>2.<
{"title":"Directive clinique no 452 : Diagnostic et prise en charge de la cholestase intrahépatique de la grossesse","authors":"Sebastian R. Hobson M.D., Ph. D., Elissa R. Cohen M.D., M.A., Shital Gandhi M.D., M. Sc. (santé publique), Venu Jain M.D., Ph. D., Kirsten M. Niles M.D., Ph. D., Marie-Ève Roy-Lacroix M.D., Bi Lan Wo M.D.","doi":"10.1016/j.jogc.2024.102619","DOIUrl":"10.1016/j.jogc.2024.102619","url":null,"abstract":"<div><h3>Objectif</h3><p>Résumer les données probantes actuelles et formuler des recommandations pour le diagnostic et la prise en charge de la cholestase intrahépatique de la grossesse.</p></div><div><h3>Population cible</h3><p>Personnes enceintes atteintes de cholestase intrahépatique de la grossesse.</p></div><div><h3>Options</h3><p>Diagnostiquer la cholestase par le dosage des acides biliaires à jeun ou non, classer la gravité de l’atteinte, déterminer le traitement à offrir, établir la méthode de surveillance du bien-être fœtal, déterminer quand procéder à un accouchement planifié.</p></div><div><h3>Bénéfices, risques et coûts</h3><p>Les personnes atteintes de cholestase intrahépatique de la grossesse présentent un risque accru d’issues périnatales défavorables (naissance prématurée, détresse respiratoire néonatale et hospitalisation en unité de soins intensifs néonatale), et de mortinaissance lorsque le taux d’acides biliaires est de 100 μmol/L ou plus. Il existe une inégalité dans la disponibilité des bilans d’acides biliaires et l’accès rapide aux résultats. Une incertitude règne quant à la manière de traiter et surveiller ces grossesses et de procéder à l’accouchement. L’optimisation des protocoles de diagnostic et de prise en charge peut améliorer les issues maternelles, fœtales et postnatales.</p></div><div><h3>Données probantes</h3><p>Des recherches ont été effectuées dans les bases de données Medline, PubMed, Embase et Cochrane Library, de leur création jusqu’à mars 2023, à partir de termes MeSH et de mots clés liés à la grossesse, à la cholestase intrahépatique de la grossesse, aux acides biliaires, au prurit, à l’acide ursodésoxycholique et à la mortinaissance. Le présent document est un résumé des données probantes et non pas une revue méthodologique.</p></div><div><h3>Méthodes de validation</h3><p>Les auteurs ont évalué la qualité des données probantes et la force des recommandations en utilisant le cadre méthodologique GRADE (Grading of Recommendations, Assessment, Development, and Evaluation). Voir l’<span><span>annexe A</span></span> (<span><span>tableau A1</span></span> pour les définitions et <span><span>tableau A2</span></span> pour l’interprétation des recommandations fortes et faibles).</p></div><div><h3>Professionnels concernés</h3><p>Professionnels de soins obstétricaux, y compris obstétriciens, médecins de famille, infirmières, sages-femmes, spécialistes en médecine fœto-maternelle et radiologistes.</p></div><div><h3>Résumé des médias sociaux</h3><p>La cholestase intrahépatique de la grossesse nécessite un bon diagnostic par dosage des acides biliaires non à jeun pour déterminer la prise en charge optimale et le moment de l’accouchement.</p></div><div><h3>DÉCLARATIONS SOMMAIRES</h3><p></p><ul><li><span>1.</span><span><p>La cholestase intrahépatique de la grossesse est un trouble gravidique fréquent qui se manifeste à la fin du deuxième trimestre ou au troisième trimestre (<em>moyenne</em>).</p></span></li><li><span>2.<","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141875128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01DOI: 10.1016/j.jogc.2024.102588
Michael C. Klein CM, MD
{"title":"Letter to the Editor: Large Databases Cannot Illuminate Practice Variation in the Use of Episiotomy","authors":"Michael C. Klein CM, MD","doi":"10.1016/j.jogc.2024.102588","DOIUrl":"10.1016/j.jogc.2024.102588","url":null,"abstract":"","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142048085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01DOI: 10.1016/j.jogc.2024.102607
JOGC Editorial Office
{"title":"Corrigendum to 2024 Abstracts: 80th Annual Clinical and Scientific Conference [Journal of Obstetrics and Gynaecology Canada (2024) Article Number 102469]","authors":"JOGC Editorial Office","doi":"10.1016/j.jogc.2024.102607","DOIUrl":"10.1016/j.jogc.2024.102607","url":null,"abstract":"","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1701216324004304/pdfft?md5=9b7a6c9a3454626082c342eed1578494&pid=1-s2.0-S1701216324004304-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142048087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01DOI: 10.1016/j.jogc.2024.102630
Graeme N. Smith MD, PhD, FRCSC, FCAHS
{"title":"L’avenir du Journal d’obstétrique et gynécologie du Canada : un mot du nouveau rédacteur en chef","authors":"Graeme N. Smith MD, PhD, FRCSC, FCAHS","doi":"10.1016/j.jogc.2024.102630","DOIUrl":"10.1016/j.jogc.2024.102630","url":null,"abstract":"","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142048084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01DOI: 10.1016/j.jogc.2024.102629
Graeme N. Smith MD, PhD, FRCSC, FCAHS
{"title":"The Future of the Journal of Obstetrics and Gynaecology Canada: A Word From its New Editor","authors":"Graeme N. Smith MD, PhD, FRCSC, FCAHS","doi":"10.1016/j.jogc.2024.102629","DOIUrl":"10.1016/j.jogc.2024.102629","url":null,"abstract":"","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142048083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01DOI: 10.1016/j.jogc.2024.102618
Sebastian R. Hobson MD, PhD, Elissa R. Cohen MD, MA, Shital Gandhi MD, MPH, Venu Jain MD, PhD, Kirsten M. Niles MD, PhD, Marie-Ève Roy-Lacroix MD, Bi Lan Wo MD
<div><h3>Objective</h3><p>To summarize the current evidence and to make recommendations for the diagnosis and management of intrahepatic cholestasis of pregnancy.</p></div><div><h3>Target Population</h3><p>Pregnant people with intrahepatic cholestasis of pregnancy.</p></div><div><h3>Options</h3><p>Diagnosing the condition using fasting or non-fasting bile acids, classifying disease severity, determining what treatment to offer, establishing how to monitor for antenatal fetal wellbeing, identifying when to perform elective birth.</p></div><div><h3>Benefits, Harms, and Costs</h3><p>Individuals with intrahepatic cholestasis of pregnancy are at increased risk of adverse perinatal outcomes including preterm birth, neonatal respiratory distress and admission to a neonatal intensive care unit, with an increased risk of stillbirth when bile acid levels are ≥100 μmol/L. There is inequity in bile acid testing availability and timely access to results, along with uncertainly of how to treat, monitor. and ultimately deliver these pregnancies. Optimization of diagnostic and management protocols can improve maternal and fetal postnatal outcomes.</p></div><div><h3>Evidence</h3><p>Medline, PubMed, Embase, and the Cochrane Library were searched from inception to March 2023, using medical subject headings (MeSH) and keywords related to pregnancy, intrahepatic cholestasis of pregnancy, bile acids, pruritis, ursodeoxycholic acid, and stillbirth. This document presents an abstraction of the evidence rather than a methodological review.</p></div><div><h3>Validation Methods</h3><p>The authors rated the quality of evidence and strength of recommendations using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. See <span><span>Appendix A</span></span> (<span><span>Tables A1</span></span> for definitions and <span><span>A2</span></span> for interpretations).</p></div><div><h3>Intended Audience</h3><p>Obstetric care providers, including obstetricians, family physicians, nurses, midwives, maternal–fetal medicine specialists, and radiologists.</p></div><div><h3>Social Media Abstract</h3><p>Intrahepatic cholestasis of pregnancy requires adequate diagnosis with non-fasting bile acid levels which guide optimal management and delivery timing.</p></div><div><h3>SUMMARY STATEMENTS</h3><p></p><ul><li><span>1.</span><span><p>Intrahepatic cholestasis of pregnancy is a common pregnancy condition manifesting in the late-second or third trimesters (<em>moderate</em>).</p></span></li><li><span>2.</span><span><p>The etiology of intrahepatic cholestasis is complex, involving a combination of hormonal factors, genetic susceptibility, and environmental influences (<em>low</em>).</p></span></li><li><span>3.</span><span><p>Intrahepatic cholestasis remains a diagnosis of exclusion and is based on the presence of maternal pruritis, predominantly of the palms and soles, along with elevated non-fasting bile acids (>19 μmol/L) (<em>moderate</em>).</p></span><
{"title":"Guideline No. 452: Diagnosis and Management of Intrahepatic Cholestasis of Pregnancy","authors":"Sebastian R. Hobson MD, PhD, Elissa R. Cohen MD, MA, Shital Gandhi MD, MPH, Venu Jain MD, PhD, Kirsten M. Niles MD, PhD, Marie-Ève Roy-Lacroix MD, Bi Lan Wo MD","doi":"10.1016/j.jogc.2024.102618","DOIUrl":"10.1016/j.jogc.2024.102618","url":null,"abstract":"<div><h3>Objective</h3><p>To summarize the current evidence and to make recommendations for the diagnosis and management of intrahepatic cholestasis of pregnancy.</p></div><div><h3>Target Population</h3><p>Pregnant people with intrahepatic cholestasis of pregnancy.</p></div><div><h3>Options</h3><p>Diagnosing the condition using fasting or non-fasting bile acids, classifying disease severity, determining what treatment to offer, establishing how to monitor for antenatal fetal wellbeing, identifying when to perform elective birth.</p></div><div><h3>Benefits, Harms, and Costs</h3><p>Individuals with intrahepatic cholestasis of pregnancy are at increased risk of adverse perinatal outcomes including preterm birth, neonatal respiratory distress and admission to a neonatal intensive care unit, with an increased risk of stillbirth when bile acid levels are ≥100 μmol/L. There is inequity in bile acid testing availability and timely access to results, along with uncertainly of how to treat, monitor. and ultimately deliver these pregnancies. Optimization of diagnostic and management protocols can improve maternal and fetal postnatal outcomes.</p></div><div><h3>Evidence</h3><p>Medline, PubMed, Embase, and the Cochrane Library were searched from inception to March 2023, using medical subject headings (MeSH) and keywords related to pregnancy, intrahepatic cholestasis of pregnancy, bile acids, pruritis, ursodeoxycholic acid, and stillbirth. This document presents an abstraction of the evidence rather than a methodological review.</p></div><div><h3>Validation Methods</h3><p>The authors rated the quality of evidence and strength of recommendations using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. See <span><span>Appendix A</span></span> (<span><span>Tables A1</span></span> for definitions and <span><span>A2</span></span> for interpretations).</p></div><div><h3>Intended Audience</h3><p>Obstetric care providers, including obstetricians, family physicians, nurses, midwives, maternal–fetal medicine specialists, and radiologists.</p></div><div><h3>Social Media Abstract</h3><p>Intrahepatic cholestasis of pregnancy requires adequate diagnosis with non-fasting bile acid levels which guide optimal management and delivery timing.</p></div><div><h3>SUMMARY STATEMENTS</h3><p></p><ul><li><span>1.</span><span><p>Intrahepatic cholestasis of pregnancy is a common pregnancy condition manifesting in the late-second or third trimesters (<em>moderate</em>).</p></span></li><li><span>2.</span><span><p>The etiology of intrahepatic cholestasis is complex, involving a combination of hormonal factors, genetic susceptibility, and environmental influences (<em>low</em>).</p></span></li><li><span>3.</span><span><p>Intrahepatic cholestasis remains a diagnosis of exclusion and is based on the presence of maternal pruritis, predominantly of the palms and soles, along with elevated non-fasting bile acids (>19 μmol/L) (<em>moderate</em>).</p></span><","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141875129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01DOI: 10.1016/j.jogc.2024.102615
Amélie Boutin PhD , Arlin Cherian MPH , Jessica Liauw MD, MHSc , Susie Dzakpasu PhD , Heather Scott MD , Michiel Van den Hof MD , Jocelynn Cook PhD , Jennifer Blake MD , K.S. Joseph MD, PhD , Canadian Perinatal Surveillance System (Public Health Agency of Canada)
{"title":"Corrigendum to Database Autopsy: An Efficient and Effective Confidential Enquiry into Maternal Deaths in Canada Journal of Obstetrics and Gynaecology Canada (JOGC). Volume 43, Issue 1 (2021) 58–66","authors":"Amélie Boutin PhD , Arlin Cherian MPH , Jessica Liauw MD, MHSc , Susie Dzakpasu PhD , Heather Scott MD , Michiel Van den Hof MD , Jocelynn Cook PhD , Jennifer Blake MD , K.S. Joseph MD, PhD , Canadian Perinatal Surveillance System (Public Health Agency of Canada)","doi":"10.1016/j.jogc.2024.102615","DOIUrl":"10.1016/j.jogc.2024.102615","url":null,"abstract":"","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1701216324004389/pdfft?md5=acd7be936704e4b61ed9d29d16b72920&pid=1-s2.0-S1701216324004389-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141766385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-26DOI: 10.1016/j.jogc.2024.102616
Jacques B.E. Versailles MD, MSc, Luis Bahamondes MD, PhD, Ana Claudia Marcelino MD, MC, Paula da Cunha Pereira RN, MC, Cassia R.T. Juliato MD, PhD
Objectives
The objective was to describe the ease and difficulty of removing intrauterine devices (IUDs).
Methods
We conducted a prospective study at the University of Campinas (UNICAMP), Faculty of Medical Sciences, UNICAMP. We included women who requested IUD removal. We excluded women with partial IUD expulsion in which the IUD was protruded at the external os. We identified difficult IUD removal when the removal was challenging, including the inability to visualize IUD strings extending from the cervical os.
Results
A total of 869 women participated. Women were aged 29.4 ± 8.0 years (mean ± SD; range 14–51) and the duration of IUD use at the time of removal was 4.3 ± 4.2 years. We found that 702 (80.8%) women had visible strings at the external os and the removals were performed at the first attempt without difficulty in 692 (79.6%) participants. The pain was more intense (>4) in cases of difficult removals. After multivariate logistic analysis, difficult removals were associated with users of IUD ≥3 years (3 times higher risk); for each previous cesarean delivery, the risk increased by 1.5 times.
Conclusions
Our study showed that IUD removal is an easy and safe procedure, with only a small proportion of women reporting significant pain with IUD removal.
{"title":"Prospective Evaluation of Ease and Difficulties of 869 Cases of Intrauterine Devices Removals","authors":"Jacques B.E. Versailles MD, MSc, Luis Bahamondes MD, PhD, Ana Claudia Marcelino MD, MC, Paula da Cunha Pereira RN, MC, Cassia R.T. Juliato MD, PhD","doi":"10.1016/j.jogc.2024.102616","DOIUrl":"10.1016/j.jogc.2024.102616","url":null,"abstract":"<div><h3>Objectives</h3><p>The objective was to describe the ease and difficulty of removing intrauterine devices (IUDs).</p></div><div><h3>Methods</h3><p>We conducted a prospective study at the University of Campinas (UNICAMP), Faculty of Medical Sciences, UNICAMP. We included women who requested IUD removal. We excluded women with partial IUD expulsion in which the IUD was protruded at the external os. We identified difficult IUD removal when the removal was challenging, including the inability to visualize IUD strings extending from the cervical os.</p></div><div><h3>Results</h3><p>A total of 869 women participated. Women were aged 29.4 ± 8.0 years (mean ± SD; range 14–51) and the duration of IUD use at the time of removal was 4.3 ± 4.2 years. We found that 702 (80.8%) women had visible strings at the external os and the removals were performed at the first attempt without difficulty in 692 (79.6%) participants. The pain was more intense (>4) in cases of difficult removals. After multivariate logistic analysis, difficult removals were associated with users of IUD ≥3 years (3 times higher risk); for each previous cesarean delivery, the risk increased by 1.5 times.</p></div><div><h3>Conclusions</h3><p>Our study showed that IUD removal is an easy and safe procedure, with only a small proportion of women reporting significant pain with IUD removal.</p></div>","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141788442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}